Anne Husebekk
Corporate Officer/Principal bij University of Tromso
Profiel
Anne Husebekk is the founder of Prophylix AS, which was founded in 2008.
She held the title of Chief Operating Officer & Project Developer.
Currently, she is a Professor & Dean-Scientific Affairs at the University of Tromso.
Dr. Husebekk earned a doctorate degree from the University of Tromso.
Actieve functies van Anne Husebekk
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | - |
Eerdere bekende functies van Anne Husebekk
| Bedrijven | Functie | Einde |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Oprichter | - |
Opleiding van Anne Husebekk
| University of Tromso | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
